Showing results (51-60 of 207) with videos related to

Sort By:
Pageof 21
SSM - Population Health|January 20, 2018
The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart diseaseJuan Merlo, Shai Mulinari, Maria Wemrell, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2011
Incidence of coronary events and case fatality rate in relation to blood lymphocyte and neutrophil countsSamuel Adamsson Eryd, J Gustav Smith, Olle Melander, et al.
Atherosclerosis|March 15, 2006
The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohortMargaretha Persson, Jan-Ake Nilsson, Jeanenne J Nelson, et al.
Angiology|August 26, 2003
Risk of myocardial infarction in relation to plasma levels of homocysteine and inflammation-sensitive proteins: a long-term nested case-control studyPeter Lind, Bo Hedblad, Björn Hultberg, et al.
Diabetes|July 29, 2003
Inflammation-sensitive plasma proteins are associated with future weight gainGunnar Engström, Bo Hedblad, Lars Stavenow, et al.
Scandinavian Journal of Public Health|April 4, 2002
Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapyBo Hedblad, Juan Merlo, Jonas Manjer, et al.
European Journal of Epidemiology|November 26, 2009
Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validityJ Gustav Smith, Pyotr G Platonov, Bo Hedblad, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 26, 2014
Plasma natriuretic peptides and incidence of subtypes of ischemic strokeJohn Berntsson, Elisabet Zia, Yan Borné, et al.
European Journal of Epidemiology|March 23, 2011
Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort studySamuel Adamsson Eryd, J Gustav Smith, Olle Melander, et al.
Atherosclerosis|February 15, 2011
Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS)Gerd Ostling, Isabel Gonçalves, John Wikstrand, et al.
Pageof 21